If you've received a COVID-19 vaccine you're able to go shopping, eat in restaurants and travel on airplanes without the same worry of catching COVID-19 that existed a year ago. But for those who are unvaccinated, catching even a mild case of COVID-19 should be a concern, according to Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"For those who have been vaccinated, life is resuming back to a sense of normalcy," says Dr. Poland. "But for the unvaccinated, they now live in a dangerous phase of the pandemic, where we're seeing circulating variants that are much more transmissible and may cause worse cases of the disease than what happened last year at this time. I think the people who are unvaccinated may not realize that."
In this Mayo Clinic Q&A podcast, Dr. Poland also offers information on more COVID-19 studies underway and he talks about COVID-19 vaccine research protocols that will be able to help scientists with other vaccine research, such as HIV vaccine research. And he answers listener questions, such as, "Do we really need to give a full vaccine dose to someone who has already had COVID-19, or might they just need a booster?"
______________________________________________
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Dr. Poland is a paid scientific adviser for Johnson & Johnson/Janssen Global Services LLC. Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co., Medicago, GlaxoSmithKline, Sanofi Pasteur, Emergent Biosolutions, Dynavax, Genentech, Eli Lilly and Company, Kentucky Bioprocessing, Bavarian Nordic, AstraZeneca, Exelixis, Regeneron, Janssen, Vyriad, Moderna, and Genevant Sciences, Inc. Dr. Poland holds patents related to vaccinia, influenza, and measles peptide vaccines. Dr. Poland has received grant funding from ICW Ventures for preclinical studies on a peptide-based COVID-19 vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies.
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. [ Ссылка ]
FOR THE MEDIA ONLY: Register at [ Ссылка ] to access clean and nat sound versions of this video on the Mayo Clinic News Network. [ Ссылка ]
Mayo Clinic [ Ссылка ]
Follow Mayo Clinic on Instagram: [ Ссылка ]
Like Mayo Clinic on Facebook: [ Ссылка ]
Follow Mayo Clinic on Twitter: [ Ссылка ]
